Literature DB >> 18815916

Tobacco smoking and risk of bladder cancer.

Paolo Boffetta1.   

Abstract

Tobacco smoking is the main known cause of urinary bladder cancer in humans. In most populations, over half of cases in men and a sizeable proportion in women are attributable to this habit. Epidemiological studies conducted in different populations have shown a linear relationship between intensity and duration of smoking and risk. Quitting smoking reduces the risk of bladder cancer. Smoking black (air-cured) cigarettes results in a higher risk than smoking blond (flue-cured) tobacco cigarettes; results on inhalation patterns and use of filter are not consistent. Cigar and pipe smoking also increases the risk of bladder cancer; data on other tobacco products are limited. The evidence for non-transitional bladder carcinoma is limited, but consistent with an increased risk. The available evidence does not point towards a different carcinogenic effect of tobacco smoking in men and women or in whites and blacks. Data on involuntary smoke and use of smokeless tobacco products are limited, but do not suggest an increased risk of bladder cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18815916     DOI: 10.1080/03008880802283664

Source DB:  PubMed          Journal:  Scand J Urol Nephrol Suppl        ISSN: 0300-8886


  31 in total

1.  Interleukin-8 (IL-8) over-production and autocrine cell activation are key factors in monomethylarsonous acid [MMA(III)]-induced malignant transformation of urothelial cells.

Authors:  C Escudero-Lourdes; T Wu; J M Camarillo; A J Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2011-10-10       Impact factor: 4.219

2.  Bioinformatics analysis of the target gene of fibroblast growth factor receptor 3 in bladder cancer and associated molecular mechanisms.

Authors:  Xing Ai; Zhuo-Min Jia; Juan Wang; Gui-Ping DI; X U Zhang; Fengling Sun; Tong Zang; Xiumei Liao
Journal:  Oncol Lett       Date:  2015-05-19       Impact factor: 2.967

3.  LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese.

Authors:  Haley L Cash; Li Tao; Jian-Min Yuan; Carmen J Marsit; E Andres Houseman; Yong-Bing Xiang; Yu-Tang Gao; Heather H Nelson; Karl T Kelsey
Journal:  Int J Cancer       Date:  2011-05-25       Impact factor: 7.396

4.  Identification of potential therapeutic targets in urothelial bladder carcinoma of Chinese population by targeted next-generation sequencing.

Authors:  Tao Wang; Zhengsheng Liu; Xuegang Wang; Peide Bai; Anran Sun; Zhiqiang Shao; Rongtuan Luo; Zhun Wu; Kaiyan Zhang; Wei Li; Wen Xiao; Bo Duan; Yongfeng Wang; Bin Chen; Jinchun Xing
Journal:  Cancer Biol Ther       Date:  2020-05-23       Impact factor: 4.742

5.  Matching cancer genomes to established cell lines for personalized oncology.

Authors:  Joel T Dudley; Rong Chen; Atul J Butte
Journal:  Pac Symp Biocomput       Date:  2011

6.  Cigarette smoke extract-induced proliferation of normal human urothelial cells via the MAPK/AP-1 pathway.

Authors:  Hao Geng; Li Zhao; Zhaofeng Liang; Zhiqiang Zhang; Dongdong Xie; Liangkuan Bi; Yi Wang; Tao Zhang; Lei Cheng; Dexin Yu; Caiyun Zhong
Journal:  Oncol Lett       Date:  2016-11-22       Impact factor: 2.967

Review 7.  Cadmium as a possible cause of bladder cancer: a review of accumulated evidence.

Authors:  Molka Feki-Tounsi; Amel Hamza-Chaffai
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-04       Impact factor: 4.223

8.  A Versatile Assay for Detection of Aberrant DNA Methylation in Bladder Cancer.

Authors:  Stella Tommasi; Ahmad Besaratinia
Journal:  Methods Mol Biol       Date:  2018

9.  Low level exposure to monomethyl arsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model.

Authors:  C Escudero-Lourdes; M K Medeiros; M C Cárdenas-González; S M Wnek; J A Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2010-01-04       Impact factor: 4.219

10.  The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer.

Authors:  Philip H Kim; Matthew Kent; Philip Zhao; John P Sfakianos; Dean F Bajorin; Bernard H Bochner; Guido Dalbagni
Journal:  World J Urol       Date:  2013-07-11       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.